MedPath
Found 1 clinical trials|View Analysis
Sort by:

THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines

Phase 1
Terminated
Conditions
COVID-19
Interventions
Biological: AAHI-SC2 Vaccine
Biological: AAHI-SC3 Vaccine
Biological: EUA or approved vaccine
First Posted Date
2022-05-11
Last Posted Date
2024-05-01
Lead Sponsor
ImmunityBio, Inc.
Target Recruit Count
60
Registration Number
NCT05370040
Locations
🇿🇦

Wits Vida, Johannesburg, South Africa

© Copyright 2025. All Rights Reserved by MedPath